2008

1. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells

   Molecular Pharmacology, Vol. 73, Núm. 4, pp. 1290-1300